Drug Shortages Update — September 26, 2021

September 25th 2021

Report: Biosimilars Have Saved the Health Care System $9.8 Billion

September 24th 2021

Amgen’s Biosimilar Trend Report finds that biosimilars have been introduced at a price that is generally 15% to 37% lower than the reference product.

Study: Insurers Pay More for Cancer Therapies Administered in Hospital Setting

September 24th 2021

Shifting cancer patients to the physician setting for administration of cancer therapies could save insurers $1.28 billion.

Onco360 Chosen as a Specialty Pharmacy for Takeda’s Exkivity

September 24th 2021

Takeda Oncology’s Exkivity treats non-small lung cancer in patients with EGFR exon 20 insertion mutations.

FDA Approves Jakafi for GVHD

September 23rd 2021

This is the fourth approval for Jakafi, a JAK1/JAK2 inhibitor.